Gilead stops Veklury study, citing enrollment challenges, changing treatment

Gilead stops Veklury study, citing enrollment challenges, changing treatment

Source: 
BioPharma Dive
snippet: 

Gilead has decided to stop a large study evaluating its COVID-19 drug Veklury in people with coronavirus infections who are at high risk of developing complications that could lead to hospitalization.